ScienceInsider reported on a petition drafted by Robert Benezra at MSKCC that urges NIH to reconsider grant application rules that limits the number of times an applicant can submit a revised version of a grant application only once instead of twice.
Pharmaceutical Business Review recently announced a Phase 2 clinical trial sponsored by The Ludwig Institute for Cancer Research (LICR) evaluating the effectiveness of ADI-PEG 20 in the treatment of small cell lung cancer (SCLC) that will take place at MSKCC and Duke University Medical Center.
Dr. Scher of MSKCC announced at the fourth annual Genitourinary Cancers Symposium that an investigational drug called abiraterone acetate may help men with hard to treat prostate cancer.